GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kineta Inc (STU:J75) » Definitions » Accumulated Depreciation

Kineta (STU:J75) Accumulated Depreciation : €0.00 Mil (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Kineta Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Kineta's quarterly accumulated depreciation declined from Sep. 2023 (€-0.07 Mil) to Dec. 2023 (€0.00 Mil) but then stayed the same from Dec. 2023 (€0.00 Mil) to Mar. 2024 (€0.00 Mil).

Kineta's annual accumulated depreciation declined from Dec. 2021 (€-0.84 Mil) to Dec. 2022 (€-0.58 Mil) but then stayed the same from Dec. 2022 (€-0.58 Mil) to Dec. 2023 (€0.00 Mil).


Kineta Accumulated Depreciation Historical Data

The historical data trend for Kineta's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kineta Accumulated Depreciation Chart

Kineta Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Accumulated Depreciation
-0.72 -0.84 -0.58 -

Kineta Quarterly Data
Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.07 -0.07 -0.07 - -

Kineta Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.


Kineta Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Kineta's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.


Kineta (STU:J75) Business Description

Industry
Traded in Other Exchanges
Address
219 Terry Avenue North, Suite 300, Seattle, WA, USA, 98109
Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients' lives. The company's asset is KVA12.1, a VISTA blocking immunotherapy.

Kineta (STU:J75) Headlines

No Headlines